来自MSN2 个月
Vittoria Biotherapeutics Showcases Advancements in T Cell Therapies at 66th ASH Annual Meeting
The Senza5™ platform improves T cell therapy by eliminating CD5-mediated immunosuppression, an approach that boosts T cell activation and ... represents a promising step forward for oncology ...